Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fei-Hu Yan

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|January 17, 2017
Long-Term Oncological Outcomes of Endoscopic Stenting as a Bridge to Surgery Versus Emergency Surgery for Malignant Colorectal Obstruction: A Comparative StudyFei-Hu Yan, Zheng Lou, Xiao-Shuang Liu, et al.
Cancer Research and Treatment|August 29, 2020
Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic CancerLin Fang, Fei-Hu Yan, Chao Liu, et al.
Nature Communications|February 10, 2021
Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infectionXiao-Lin Jiang, Guo-Lin Wang, Xiang-Na Zhao, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|January 17, 2017
Long-Term Oncological Outcomes of Endoscopic Stenting as a Bridge to Surgery Versus Emergency Surgery for Malignant Colorectal Obstruction: A Comparative StudyFei-Hu Yan, Zheng Lou, Xiao-Shuang Liu, et al.
Cancer Research and Treatment|August 29, 2020
Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic CancerLin Fang, Fei-Hu Yan, Chao Liu, et al.
Nature Communications|February 10, 2021
Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infectionXiao-Lin Jiang, Guo-Lin Wang, Xiang-Na Zhao, et al.
Pageof 2